You might be able to give yourself shots of your medicine at home as part of your treatment for rheumatoid arthritis. Self-injections may be an option for you if your RA doctor (rheumatologist) ...

Methotrexate injection is indicated for certain cancers as well as for the treatment of rheumatoid arthritis and other ...

A re-evaluation was undertaken in the Arthritis Clinic of the Philadelphia General Hospital to compare results with those obtained by other investigators. Included in this study are a number of cases ...

Rheumatoid arthritis (RA) is a chronic inflammatory condition that causes joint and muscle pain. There’s no cure for RA, but early treatment can help manage the condition, keep you active, and improve ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the BREVACTA study of RoACTEMRA (tocilizumab, known as ACTEMRA outside Europe) given as a subcutaneous (SC) injection to patients with ...

Intra-articular administration of corticosteroids is a standard therapeutic option for patients with rheumatoid arthritis (RA) who have polyarticular disease activity. Whether or not polyarticular ...

Although there are a range of drugs that can treat rheumatoid arthritis (RA), they can all have significant side effects. “Some are common and some not so common,” says Diane Horowitz, MD, an ...

Oslo, Norway, 15 November 2013 - Algeta ASA (OSE: ALGETA) announces today that Bayer has received marketing authorisation from the European Commission for Xofigo ® (radium Ra 223 dichloride) solution ...

There’s no single treatment plan for rheumatoid arthritis (RA). If you have this inflammatory disease, chances are you’ll need to change your medication one or more times along the way. There are many ...

Dear Dr. Roach • I have had rheumatoid arthritis since 2010. I take two naproxen a day sometimes, but only one if the pain is not bad. I am allergic to several medications. My doctor wants me to use ...

STAINES-UPON-THAMES, United Kingdom, June 13, 2019 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a global specialty biopharmaceutical company, is reporting that all primary and secondary outcome ...